Dr. Nour-Omid has more than 30 years of experience as a technology leader, executive and founder of multiple companies. He first joined Think Passenger as the CEO over four years before assuming the role of Executive Chairman.
Dr. Nour-Omid was a co-founder of Scopus Technology and served as its Chief Technology Officer and a member of its Board of Directors. At Scopus, he played a key role in the development of its CRM Application Software that generated over $100 million revenues in its first six years, in its successful initial public offering in 1995 and its merger with Siebel Systems, Inc., in 1998. Dr. Nour-Omid was also a founder of StudioXchange, Inc., a provider of production services platform for the entertainment industry. StudioXchange was acquired by IFILM in 2000 and is now part of Viacom. Dr. Nour-Omid was a founding member of Shelter Capital Partners, LLC., a private venture capital firm in Southern California with investments in Information Technology. He has held executive-level and management positions at Essentus, Inc., a provider of supply chain software for the apparel industry and was a consulting scientist at the Lockheed Palo Alto Research Laboratory.
Dr. Nour-Omid currently is a director of Hyginex, Inc., a provider of electronic hand hygiene compliance solution for the reduction of hospital acquired infections (HAIs); a director of Elsight, a provider of real time wireless transmission solution for captured video; and Chairman of Nestivity, inc., a platform provider for engaging Twitter followers through discussions and tweet casts.
Dr. Nour-Omid earned a B.S. from the University of London's Imperial College, and an M.S. in Structural Engineering, M.A. in Mathematics and Ph.D. in Computer Simulation from the University of California, Berkeley.
Board & Advisor Roles (4)Update
|Apr 29, 2014||TechCrunch - Adly And Nestivity Merge, Will Integrate Their Social Marketing Tools|